Picture of Climb Bio logo

CLYM — Climb Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Eliem Therapeutics Announces Plans To Explore Strategic Alternatives

July 20 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS ANNOUNCES PLANS TO EXPLORE STRATEGIC
ALTERNATIVES
    * ELIEM THERAPEUTICS INC - HAS MADE DETERMINATION TO HALT
FURTHER
DEVELOPMENT OF ITS KV7 PROGRAM
    * ELIEM THERAPEUTICS INC - WILL EXPLORE POTENTIAL STRATEGIC
ALTERNATIVES THAT MAY INCLUDE, BUT ARE NOT LIMITED TO, AN
ACQUISITION, MERGER
    * ELIEM THERAPEUTICS: AS OF JUNE 30, PRELIMINARY UNAUDITED
AMOUNT
OF ABOUT $102.6 MILLION IN CASH, CASH EQUIVALENTS AND
INVESTMENTS IN MARKETABLE SECURITIES
    * ELIEM THERAPEUTICS INC - HAS ENGAGED LEERINK PARTNERS TO
ACT AS
A STRATEGIC ADVISOR IN PROCESS

Source text for Eikon:  ID:nGNX1pMtyH 
Further company coverage:  ELYM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Climb Bio

See all news